<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/767FF286-9A6A-483E-88DD-132919732774"><gtr:id>767FF286-9A6A-483E-88DD-132919732774</gtr:id><gtr:name>James Hutton Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AB871950-0395-4429-A864-DBE2C1F8A574"><gtr:id>AB871950-0395-4429-A864-DBE2C1F8A574</gtr:id><gtr:name>University of Cyprus</gtr:name><gtr:address><gtr:line1>75 Kallipoleos Street</gtr:line1><gtr:line2>PO BOX 20537</gtr:line2><gtr:line3>1678, Nicosia</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/59F09DF9-DD13-4FFB-9429-2993C1DD4F54"><gtr:id>59F09DF9-DD13-4FFB-9429-2993C1DD4F54</gtr:id><gtr:name>MRC Human Reproductive Sciences Unit</gtr:name><gtr:address><gtr:line1>Centre for Reproductive Biology</gtr:line1><gtr:line2>37 Chalmers Street</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH3 9EW</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/59F09DF9-DD13-4FFB-9429-2993C1DD4F54"><gtr:id>59F09DF9-DD13-4FFB-9429-2993C1DD4F54</gtr:id><gtr:name>MRC Human Reproductive Sciences Unit</gtr:name><gtr:address><gtr:line1>Centre for Reproductive Biology</gtr:line1><gtr:line2>37 Chalmers Street</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH3 9EW</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/767FF286-9A6A-483E-88DD-132919732774"><gtr:id>767FF286-9A6A-483E-88DD-132919732774</gtr:id><gtr:name>James Hutton Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB871950-0395-4429-A864-DBE2C1F8A574"><gtr:id>AB871950-0395-4429-A864-DBE2C1F8A574</gtr:id><gtr:name>University of Cyprus</gtr:name><gtr:address><gtr:line1>75 Kallipoleos Street</gtr:line1><gtr:line2>PO BOX 20537</gtr:line2><gtr:line3>1678, Nicosia</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4038FC88-0836-4B4B-95A0-A4432FE7BD34"><gtr:id>4038FC88-0836-4B4B-95A0-A4432FE7BD34</gtr:id><gtr:firstName>Alan</gtr:firstName><gtr:surname>McNeilly</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U127685843"><gtr:id>A387C058-E0F6-4C0E-A195-180376D58D79</gtr:id><gtr:title>Gene targeting and control of ovarian function</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U127685843</gtr:grantReference><gtr:abstractText>In adult reproductive life only only a minute fraction of all the eggs in an ovary laid down in fetal life ever grow to maturity and are released at ovulation in mid cycle where the mature egg can be fertilised and pregnancy established. Each day, factors released from the egg activate the growth of the follicle, but almost all eggs and follicles die until no eggs are left in the ovary at the menopause. During each menstrual cycle gonadotrophic hormones secreted from the pituitary gland stimulate follicle growth towards mid cycle when all but one follicle is selected to continue growth to ovulation This process can be disrupted for instance by excess androgen secretion by the ovary in PCOS. We are investigating the factors within the developing follicle that makes the follicle sensitive to gonadotrophins, and stops follicles from dying, to identify novel targets to manipulate follicle survival to promote or inhibit fertility. When follicle death does not occur in an ordered manner, ovarian tumours may arise. We are developing model systems to analyse the course of ovarian tumour formation and investigating different methods of gene targeting to normal ovaries including ultrasound to provide potential novel treatments to regulate fertility.</gtr:abstractText><gtr:technicalSummary>The program will investigate the regulation of follicle activation, growth and atresia, and relate this to the causes of ovarian tumour formation. A principal aim is to develop an alternative model to the multi-ovular rodent to analyse gene function in ovarian activity in a mono-ovular species equivalent to the human through targeted cell-specific time-controlled gene manipulation. Studies in the Dazlko mouse, where all oocytes are lost after birth, showed that adult ovaries lacking oocytes produce steroids and develop ovarian tumours, providing a new model for some types of ovarian tumours in women. Heterozygous Dazlko mice have a reduction of total follicle numbers but increased litter sizes providing a new model for the role of oocyte factors in regulating gonadotrophin sensitivity and resistance to atresia. Although Polycystic Ovaran Syndrome (PCOS) is one of the most common causes of fertility problems in women exacerbated by increase in body weight, and associated with increased androgens, the causes of this disease and the role of androgens in the ovary remains unclear. We are investigating the function of androgens in the ovary both in a sheep model of PCOS, and using transgenc mice in which the androgen receptor (AR) can be removed in specific cell types within the ovary while leaving ARs in other tissues unaffected. Our observations in the Dazl kO mouse that stromal/thecal cells remain functional in ovaries devoid of oocytes and produce androgens potentially associated with tumour development suggest that control of androgen metabolism and regulation of thecal cell lifespan is important. We hypothesise that stromal/thecal cells require to be removed from the ovary in an ordered manner, which normally occurs as follicles become atretic and die. In the absence of oocytes and normal follicle development in our Dazlko mice, this normal pathway of thecal cell demise is absent, there is lack of control of stromal cell function, and this results in tumour formation either through an action of androgens or converted estrogens. Following our identification of the BMP1B receptor as the prolificacy gene in Booroola sheep, we continue collaborative studies on the role of the TGF beta superfamily of proteins, particularly activins and BMPs, in ovarian and pituitary function. Our studies have highlighted the need to develop a new in vivo model to evaluate intra-ovarian factors in the regulation of follicle growth and development in a mono-ovular species rather than relying entirely on the multi-ovulating rodent models for the human. Using our expertise in sheep ovarian and pituitary biology, our ability to monitor and manipulate the endocrine environment in sheep, and our collaboration with Medical Physics to enhance ultrasound-imaging techniques, we are developing gene delivery vectors for cell specific gene targeting to increase or decrease specific gene expression. This will allow for the first time a comparison between multi- and mono-ovular species. Overall these studies may lead to new methods of regulating ovarian function and fertility, and potentially ovarian tumour formation.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>3081054</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cyprus</gtr:collaboratingOrganisation><gtr:country>Cyprus, Republic of</gtr:country><gtr:description>Development of contrast-enhanced ultrasonography using the sheep ovarian model of microvascular regulation</gtr:description><gtr:id>8AE46BDF-5915-4100-94B0-294701FEF518</gtr:id><gtr:impact>We have seen for the first time the changes in microvasculature in an organ after physiological manipulations known to alter the function of the tissue. New methods have been developed to analyse these data with direct application to routine ultrasound. The collaborations with our cardiovascular and gynaecological colleagues is leading to novel potential applications. The potential to use contrast agents as gene delivery vehicles is being explored with our USA collaborator. A phase 1 clinical study is being planned to identify changes in uterine vasculature related to preeclampsia and other conditions related to poor pregnancy outcomes.</gtr:impact><gtr:outcomeId>D846F5D26ED-2</gtr:outcomeId><gtr:partnerContribution>The collaboration has allowed us to develop novel methods of contrast-enhanced ultrasound to monitor changes in the microvasculature in real time, by developing new software and supplying the knowledge of the latest technology to achieve our aims. In addition the USA connection has provided rfree reagent for these studies and the latest methods for targeting genes using the contrast agents.development of new softwaredevelopment of new software</gtr:partnerContribution><gtr:piContribution>Reagents have been supplied as necessary at no cost. WE have developed the use of the sheep ovary and particularly the corpus luteum as a model for the microvasculature. Our extensive knowledge of the control of ovarian function in sheep and how to manipulate this, together with the surgical skills to allow proper visualisation of the ovaries, and the infrastructure of our sheep facility allowed this unique program to proceed.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine Manchester</gtr:department><gtr:description>Dissection of a novel molecular pathway involved in seasonal timing in a melatonin-target tissue using an experimental and systems-level approach</gtr:description><gtr:id>83454802-C377-4A11-B524-83FC81B82DA5</gtr:id><gtr:impact>We have identified a number of genes that are either up or down regulated by melatonin and are currently analysing the transcriptional regulation of these genes. The bioinformatics involved have been extremely helpful in our own research program and we have benefited from using the latest technology, both for arrays and the intepretation of the results.WE have now established that some putative transcription factors in the brain do not act in this way in the pituitary, adding further interest to the mechanisms involved.</gtr:impact><gtr:outcomeId>1DCA0DC09E4-1</gtr:outcomeId><gtr:partnerContribution>A technical post has been assigned to me to undertake collaborative studies on this project.</gtr:partnerContribution><gtr:piContribution>We have trained the technician in the required methods and she is utilising our skills to analyse the results. I assist in experimental design and execution of the in vivo sheep studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Cardiovascular Science</gtr:department><gtr:description>Development of contrast-enhanced ultrasonography using the sheep ovarian model of microvascular regulation</gtr:description><gtr:id>9E94C5C8-DC2F-4BC6-8FEE-CA15BB6796CC</gtr:id><gtr:impact>We have seen for the first time the changes in microvasculature in an organ after physiological manipulations known to alter the function of the tissue. New methods have been developed to analyse these data with direct application to routine ultrasound. The collaborations with our cardiovascular and gynaecological colleagues is leading to novel potential applications. The potential to use contrast agents as gene delivery vehicles is being explored with our USA collaborator. A phase 1 clinical study is being planned to identify changes in uterine vasculature related to preeclampsia and other conditions related to poor pregnancy outcomes.</gtr:impact><gtr:outcomeId>D846F5D26ED-1</gtr:outcomeId><gtr:partnerContribution>The collaboration has allowed us to develop novel methods of contrast-enhanced ultrasound to monitor changes in the microvasculature in real time, by developing new software and supplying the knowledge of the latest technology to achieve our aims. In addition the USA connection has provided rfree reagent for these studies and the latest methods for targeting genes using the contrast agents.development of new softwaredevelopment of new software</gtr:partnerContribution><gtr:piContribution>Reagents have been supplied as necessary at no cost. WE have developed the use of the sheep ovary and particularly the corpus luteum as a model for the microvasculature. Our extensive knowledge of the control of ovarian function in sheep and how to manipulate this, together with the surgical skills to allow proper visualisation of the ovaries, and the infrastructure of our sheep facility allowed this unique program to proceed.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Reproductive Biology</gtr:department><gtr:description>Polycystic Ovarian Syndrome: modelling development, phenotype and progression using a developmental paradigm</gtr:description><gtr:id>1F1B8B9A-EF87-47B4-90D0-FBB36ECF263A</gtr:id><gtr:impact>We have shown for the first time that alterations in levels of steroids directly in the fetus can program aspects of adult metabolic activity with potential consequences on ovarian and thus, reproductive function in the adult. The results are dissecting apart the different aspects of the complicated phenotype of PCOS in women. OU recent results in the rat model have shown that the effects on metabolism are related to both altered fettle androgen and oestrogen action with subtle variations in effect.</gtr:impact><gtr:outcomeId>93EA0BA4BD4-1</gtr:outcomeId><gtr:partnerContribution>The collaboration has allowed us to develop a novel model of PCOS. The skills of my reproductive medicine clinical colleague has allowed us to perfect the use of direct injection of androgens in the sheep fetus, to explore programming effects in adult life.It has also led to further collaborations and development of a number of new initiatives.</gtr:partnerContribution><gtr:piContribution>We have supplied extensive knowledge of sheep pituitary regulation of ovarian function to thse studies. In addition we have added information from our own studies on PCOS in rats to complement these studies. WE are continuing these studies with renewed funding for the MRC to explore which steroids are involved in programming the metabolic and ovarian disruption that occurs in PCOS.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biological Sciences Liverpool</gtr:department><gtr:description>Temporal analysis of the dynamic regulation of pituitary gene transcription</gtr:description><gtr:id>104F0D52-F013-41D9-9B7B-43D8519D8DA3</gtr:id><gtr:impact>The group have described for the first time regulation of transcription in real time in tissues in relation to individual cells and the evolution of this control during development. Results showed that transcription is an on and off system within individual cells.More recently the input of mathematical modelling has proved to be immensely useful in interpretation of the data, and added to our potential for our own research.</gtr:impact><gtr:outcomeId>27179177C2B-2</gtr:outcomeId><gtr:partnerContribution>The collaboration has educated us in the application of mathematics and systems biology approach to our research, and state of the art real time imaging.state of the art real time imaging.generation of transgenic rats</gtr:partnerContribution><gtr:piContribution>Reagents have been supplied as necessary at no cost, but we have benefited from the interactions in which we have used our knowledge of endocrine regulation of prolactin and its role in reproductive processes, and our knowledge pituitary function and control to design experiments. We have also provided expert knowledge in imaging and hormone assays and how to run the animal experiments involved.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Aberdeen</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Applied Medicine</gtr:department><gtr:description>Identification of the THOKA fecundity gene in sheep</gtr:description><gtr:id>764B647B-0E03-4D3E-BAE7-0AA8F9502501</gtr:id><gtr:impact>We have identified and published (Nicol et al 2009; Reproduction 138: 921-933) the mutation so that all sheep in the flock can be genotyped. Our consortium are finalising an agreement with Innovis in Aberystwyth to exploit this genotype for the sheep industry introducing into commercial flocks for production. We are currently examining the mechanisms whereby there is an increase in fertility and fecundity in heterozygous sheep, and whether we can reverse the infertility in homozygous sheep by intra-ovarian gene transfer using lentiviral vectors both in vivo and in vitro.</gtr:impact><gtr:outcomeId>BECD5253EAE-3</gtr:outcomeId><gtr:partnerContribution>The genetics for identifying the chromosomal gene location was provided by the Roslin Institute.The sheep are supplied by the Macaulay Institute for our studies at nominal costWe have undertaken a proteomic screen of ovaries from the Thoka homozygous sheep in comparison with late pregnancy fettle sheep ovaries and identified a number of proteins that are either increased or decreased related to oocyte activation and follicle development. This has been mutually beneficial giving insight into how environmental factors may influence ovarian programming in adult life.</gtr:partnerContribution><gtr:piContribution>Having established the phenotype of the homozygous sheep which have inactive ovaries as adults, we then screened for candidate genes and identified a single base mutation leading to a single amino acid change in the oocyte specific GDF9. We determined the phenotype effect within the ovary and established the physiological consequences of the mutation. Subsequently the Roslin team showed that this mutation was the only one to explain the effects on fertility. We are now exploring how the mutation increases fertility in the heterozygous sheep.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>James Hutton Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Identification of the THOKA fecundity gene in sheep</gtr:description><gtr:id>F165E268-2448-414B-A489-ACFDCE03DF54</gtr:id><gtr:impact>We have identified and published (Nicol et al 2009; Reproduction 138: 921-933) the mutation so that all sheep in the flock can be genotyped. Our consortium are finalising an agreement with Innovis in Aberystwyth to exploit this genotype for the sheep industry introducing into commercial flocks for production. We are currently examining the mechanisms whereby there is an increase in fertility and fecundity in heterozygous sheep, and whether we can reverse the infertility in homozygous sheep by intra-ovarian gene transfer using lentiviral vectors both in vivo and in vitro.</gtr:impact><gtr:outcomeId>BECD5253EAE-2</gtr:outcomeId><gtr:partnerContribution>The genetics for identifying the chromosomal gene location was provided by the Roslin Institute.The sheep are supplied by the Macaulay Institute for our studies at nominal costWe have undertaken a proteomic screen of ovaries from the Thoka homozygous sheep in comparison with late pregnancy fettle sheep ovaries and identified a number of proteins that are either increased or decreased related to oocyte activation and follicle development. This has been mutually beneficial giving insight into how environmental factors may influence ovarian programming in adult life.</gtr:partnerContribution><gtr:piContribution>Having established the phenotype of the homozygous sheep which have inactive ovaries as adults, we then screened for candidate genes and identified a single base mutation leading to a single amino acid change in the oocyte specific GDF9. We determined the phenotype effect within the ovary and established the physiological consequences of the mutation. Subsequently the Roslin team showed that this mutation was the only one to explain the effects on fertility. We are now exploring how the mutation increases fertility in the heterozygous sheep.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine Manchester</gtr:department><gtr:description>Temporal analysis of the dynamic regulation of pituitary gene transcription</gtr:description><gtr:id>83B0599D-18C5-4FAD-8B9D-8F64DFCBEAD7</gtr:id><gtr:impact>The group have described for the first time regulation of transcription in real time in tissues in relation to individual cells and the evolution of this control during development. Results showed that transcription is an on and off system within individual cells.More recently the input of mathematical modelling has proved to be immensely useful in interpretation of the data, and added to our potential for our own research.</gtr:impact><gtr:outcomeId>27179177C2B-1</gtr:outcomeId><gtr:partnerContribution>The collaboration has educated us in the application of mathematics and systems biology approach to our research, and state of the art real time imaging.state of the art real time imaging.generation of transgenic rats</gtr:partnerContribution><gtr:piContribution>Reagents have been supplied as necessary at no cost, but we have benefited from the interactions in which we have used our knowledge of endocrine regulation of prolactin and its role in reproductive processes, and our knowledge pituitary function and control to design experiments. We have also provided expert knowledge in imaging and hormone assays and how to run the animal experiments involved.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Roslin Institute</gtr:department><gtr:description>Identification of the THOKA fecundity gene in sheep</gtr:description><gtr:id>81AFB09E-DC81-4F51-A729-43F7669ED3E2</gtr:id><gtr:impact>We have identified and published (Nicol et al 2009; Reproduction 138: 921-933) the mutation so that all sheep in the flock can be genotyped. Our consortium are finalising an agreement with Innovis in Aberystwyth to exploit this genotype for the sheep industry introducing into commercial flocks for production. We are currently examining the mechanisms whereby there is an increase in fertility and fecundity in heterozygous sheep, and whether we can reverse the infertility in homozygous sheep by intra-ovarian gene transfer using lentiviral vectors both in vivo and in vitro.</gtr:impact><gtr:outcomeId>BECD5253EAE-1</gtr:outcomeId><gtr:partnerContribution>The genetics for identifying the chromosomal gene location was provided by the Roslin Institute.The sheep are supplied by the Macaulay Institute for our studies at nominal costWe have undertaken a proteomic screen of ovaries from the Thoka homozygous sheep in comparison with late pregnancy fettle sheep ovaries and identified a number of proteins that are either increased or decreased related to oocyte activation and follicle development. This has been mutually beneficial giving insight into how environmental factors may influence ovarian programming in adult life.</gtr:partnerContribution><gtr:piContribution>Having established the phenotype of the homozygous sheep which have inactive ovaries as adults, we then screened for candidate genes and identified a single base mutation leading to a single amino acid change in the oocyte specific GDF9. We determined the phenotype effect within the ovary and established the physiological consequences of the mutation. Subsequently the Roslin team showed that this mutation was the only one to explain the effects on fertility. We are now exploring how the mutation increases fertility in the heterozygous sheep.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:description>Development of contrast-enhanced ultrasonography using the sheep ovarian model of microvascular regulation</gtr:description><gtr:id>2C6807A6-A9A2-44B2-B893-F5EA3CA838AB</gtr:id><gtr:impact>We have seen for the first time the changes in microvasculature in an organ after physiological manipulations known to alter the function of the tissue. New methods have been developed to analyse these data with direct application to routine ultrasound. The collaborations with our cardiovascular and gynaecological colleagues is leading to novel potential applications. The potential to use contrast agents as gene delivery vehicles is being explored with our USA collaborator. A phase 1 clinical study is being planned to identify changes in uterine vasculature related to preeclampsia and other conditions related to poor pregnancy outcomes.</gtr:impact><gtr:outcomeId>D846F5D26ED-3</gtr:outcomeId><gtr:partnerContribution>The collaboration has allowed us to develop novel methods of contrast-enhanced ultrasound to monitor changes in the microvasculature in real time, by developing new software and supplying the knowledge of the latest technology to achieve our aims. In addition the USA connection has provided rfree reagent for these studies and the latest methods for targeting genes using the contrast agents.development of new softwaredevelopment of new software</gtr:partnerContribution><gtr:piContribution>Reagents have been supplied as necessary at no cost. WE have developed the use of the sheep ovary and particularly the corpus luteum as a model for the microvasculature. Our extensive knowledge of the control of ovarian function in sheep and how to manipulate this, together with the surgical skills to allow proper visualisation of the ovaries, and the infrastructure of our sheep facility allowed this unique program to proceed.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Cardiovascular Science</gtr:department><gtr:description>Temporal analysis of the dynamic regulation of pituitary gene transcription</gtr:description><gtr:id>138A7D05-5FC8-4051-8013-FC3FEE8204FC</gtr:id><gtr:impact>The group have described for the first time regulation of transcription in real time in tissues in relation to individual cells and the evolution of this control during development. Results showed that transcription is an on and off system within individual cells.More recently the input of mathematical modelling has proved to be immensely useful in interpretation of the data, and added to our potential for our own research.</gtr:impact><gtr:outcomeId>27179177C2B-3</gtr:outcomeId><gtr:partnerContribution>The collaboration has educated us in the application of mathematics and systems biology approach to our research, and state of the art real time imaging.state of the art real time imaging.generation of transgenic rats</gtr:partnerContribution><gtr:piContribution>Reagents have been supplied as necessary at no cost, but we have benefited from the interactions in which we have used our knowledge of endocrine regulation of prolactin and its role in reproductive processes, and our knowledge pituitary function and control to design experiments. We have also provided expert knowledge in imaging and hormone assays and how to run the animal experiments involved.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>talk to prospective medical students</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F9BD8533-0FBF-40EF-AB44-4B160254500C</gtr:id><gtr:impact>Discussed the alternative path of a research scientist for the school students if they did not get into medical school but still wanted to be involved in health care.

Very positive feedback from the students who attended this meeting organised by the Pathways to the Professions of Edinburgh University</gtr:impact><gtr:outcomeId>E7CBAD82BD9</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture series</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>19942D1A-300D-4D90-A4BE-6C4C3E19B387</gtr:id><gtr:impact>I organise a series of 5 public lectures each autumn and winter from the Centre for Reproductive Biology. Each lecture consist of a clinician presenting a pathology as presented in the clinic and a researcher describing the type of research we are undertaking to help treat the pathology.

Reports in the local press and in MRC news. Feedback extremely positive and raising the profile of the MRC and university.</gtr:impact><gtr:outcomeId>BA2EC000A8F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>808144</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>58294EEC-7300-4AA4-8CAB-548879CA56A4</gtr:id><gtr:outcomeId>UhV2JTZtamf0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>679367</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Research Grant</gtr:description><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>79485410-BFCE-4AC5-B626-4A2BE976F468</gtr:id><gtr:outcomeId>693A12EB75C0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>329460</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9B33393D-4A31-4387-A19C-2FD1BBAF1607</gtr:id><gtr:outcomeId>C8D8FF20B0C0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>888149</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>594919B7-9F16-404E-BC19-8974DA9AF54B</gtr:id><gtr:outcomeId>26E7BB555A40</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Weatherall Committee on use of primates in research</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F36225E7-67E6-4FB6-B3B8-1EDAE41A35F6</gtr:id><gtr:impact>Explained to the committee the reproductive biology of the primate and how there were several unique features that could not be replicated in mouse or rat models. This appeared in the final report.; Empahsised the importance of primates for some research programs in reproductive medicine in the MRC.</gtr:impact><gtr:outcomeId>FC33482593F</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the Home Office Animal Procedures Committee for 8 years, and was Chairman of the Primate sub-committee for 3 of these years, preparing reports for the APC and minister.</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E15DD827-0731-4CE2-A837-9EBA82F713BF</gtr:id><gtr:impact>Prepared several reports and on committee obviously joined discussions re future of research with animals, particularly primates. These included supply of primates from oversees suppliers, report on supposed overbreeding of animals for research, interactions with the pharmaceutical indusrty</gtr:impact><gtr:outcomeId>E8B20C92C22</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We are developing a new mouse model of ovarian cancer development which may allow us to track the aetiology of the disease and design new tools for monitoring women.</gtr:description><gtr:id>0ED9880E-EC88-437A-9575-8280B8E2EDE1</gtr:id><gtr:impact>Local talks with caner experts suggest that this will be a valuable tool - mouse model - when we have fully evaluated it.</gtr:impact><gtr:outcomeId>EC50B2288CB</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>ovarian tumor model</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A4E8A0A1-7B3F-4C9F-AE7C-14FCF6255094</gtr:id><gtr:title>Theca: the forgotten cell of the ovarian follicle.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7428120f3ad7c1593e45ddd895029c3"><gtr:id>b7428120f3ad7c1593e45ddd895029c3</gtr:id><gtr:otherNames>Young JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>kvT6yhM8LeM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56E15C1F-2A89-403F-926F-090F7BB8D7CE</gtr:id><gtr:title>Regulation of folliculogenesis and the determination of ovulation rate in ruminants.</gtr:title><gtr:parentPublicationTitle>Reproduction, fertility, and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e4f39e5f0bac3be7b5feea202d5a6b8"><gtr:id>7e4f39e5f0bac3be7b5feea202d5a6b8</gtr:id><gtr:otherNames>Scaramuzzi RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1031-3613</gtr:issn><gtr:outcomeId>e6dTeVuvkC5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47D19F28-55DF-4498-956F-C43CAFCC33DB</gtr:id><gtr:title>Elevated prolactin levels immediately precede decisions to babysit by male meerkat helpers.</gtr:title><gtr:parentPublicationTitle>Hormones and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7400fe5ba53f413e568a8e494be069dd"><gtr:id>7400fe5ba53f413e568a8e494be069dd</gtr:id><gtr:otherNames>Carlson AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0018-506X</gtr:issn><gtr:outcomeId>89174481B0A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EB5C638-483D-4F13-BE44-394840F81031</gtr:id><gtr:title>Activin signals via SMAD2/3 between germ and somatic cells in the human fetal ovary and regulates kit ligand expression.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3d9fb36e035c95671e968dd340e8194"><gtr:id>b3d9fb36e035c95671e968dd340e8194</gtr:id><gtr:otherNames>Coutts SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>026C21EC8E7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B553CE79-7166-4AFD-ACCA-B8D89D795D03</gtr:id><gtr:title>Timing of preovulatory LH surge and ovulation in superovulated sheep are affected by follicular status at start of the FSH treatment.</gtr:title><gtr:parentPublicationTitle>Reproduction in domestic animals = Zuchthygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f38c56ac5eb851fcc875526fd69417af"><gtr:id>f38c56ac5eb851fcc875526fd69417af</gtr:id><gtr:otherNames>Veiga-Lopez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0936-6768</gtr:issn><gtr:outcomeId>B8803024BCD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BD232FB-5477-499E-B857-E3B6DDB6CCFF</gtr:id><gtr:title>LIM homeodomain transcription factor Isl-1 enhances follicle stimulating hormone-beta and luteinizing hormone-beta gene expression and mediates the activation of leptin on gonadotropin synthesis.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1ae91a136cc1808e002adb45e242f69"><gtr:id>e1ae91a136cc1808e002adb45e242f69</gtr:id><gtr:otherNames>Wu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>AT8AVrSccGP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF051AB6-F3BA-4BE0-8089-F549A9C8C57B</gtr:id><gtr:title>Bone morphogenetic protein-4 interacts with activin and GnRH to modulate gonadotrophin secretion in LbetaT2 gonadotrophs.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63ee45c8bf86bf1fff7e1dacba7321fd"><gtr:id>63ee45c8bf86bf1fff7e1dacba7321fd</gtr:id><gtr:otherNames>Nicol L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>9E2DD88CA0C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>458B3581-4A30-4CF6-BFD0-F654C75F02E3</gtr:id><gtr:title>Effects of breed on kinetics of ovine FSH and ovarian response in superovulated sheep.</gtr:title><gtr:parentPublicationTitle>Theriogenology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19a6b227a2dbf109653f21de3cbb6432"><gtr:id>19a6b227a2dbf109653f21de3cbb6432</gtr:id><gtr:otherNames>Ammoun I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0093-691X</gtr:issn><gtr:outcomeId>5BDA5A9DD59</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64E66E13-342F-4328-B99A-AC166EFCAE54</gtr:id><gtr:title>Deletion of androgen receptor in the smooth muscle of the seminal vesicles impairs secretory function and alters its responsiveness to exogenous testosterone and estradiol.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2034c2bebf4f8694cade299efecbb4e6"><gtr:id>2034c2bebf4f8694cade299efecbb4e6</gtr:id><gtr:otherNames>Welsh M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>oewryoYdKMF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DDD2725-DEA3-4C9D-82EE-08E00358CDEF</gtr:id><gtr:title>Effects of growth hormone and gonadotrophin releasing hormone antagonists on ovarian follicle growth in sheep</gtr:title><gtr:parentPublicationTitle>JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e26ebae3be3466886d57abf04aaad9d"><gtr:id>2e26ebae3be3466886d57abf04aaad9d</gtr:id><gtr:otherNames>Anover P. Gonzalez</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0140-7783</gtr:issn><gtr:outcomeId>5a3516b28c7037.71836300</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF914B45-7CF0-4632-9A98-07F5A6D38FA7</gtr:id><gtr:title>Inhibitor of differentiation (Id) genes are expressed in the steroidogenic cells of the ovine ovary and are differentially regulated by members of the transforming growth factor-beta family.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa1786b165b60ceff9c0741dcea3a5cb"><gtr:id>fa1786b165b60ceff9c0741dcea3a5cb</gtr:id><gtr:otherNames>Hogg K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>AFQ26gxSBjp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D521E46-3778-49F0-BF4B-3BB254FB85BC</gtr:id><gtr:title>Effect of androgen treatment during foetal and/or neonatal life on ovarian function in prepubertal and adult rats.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b73aad72b7ef23b9b31bd5b4ea8f7fc"><gtr:id>9b73aad72b7ef23b9b31bd5b4ea8f7fc</gtr:id><gtr:otherNames>Tyndall V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>MGtfF7UQB3c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E756D95-FE4D-45FA-ACDC-2487D73A6A23</gtr:id><gtr:title>Effects of growth hormone and gonadotrophin releasing hormone antagonists on ovarian follicle growth in sheep.</gtr:title><gtr:parentPublicationTitle>Journal of veterinary pharmacology and therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf381918a3a98173d25c513192d0b60f"><gtr:id>cf381918a3a98173d25c513192d0b60f</gtr:id><gtr:otherNames>Gonzalez A?over P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0140-7783</gtr:issn><gtr:outcomeId>A72F71D0A86</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D8A604B-641D-43D7-AC8F-03782729909B</gtr:id><gtr:title>Decreased oocyte DAZL expression in mice results in increased litter size by modulating follicle-stimulating hormone-induced follicular growth.</gtr:title><gtr:parentPublicationTitle>Biology of reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a7d47a0d09e7a03916f076b5194a259"><gtr:id>7a7d47a0d09e7a03916f076b5194a259</gtr:id><gtr:otherNames>McNeilly JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3363</gtr:issn><gtr:outcomeId>ovnK5wM3p3H</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7247BC9F-4346-4BB9-9F24-CC7221A923B4</gtr:id><gtr:title>The activin receptor-like kinase 6 Booroola mutation enhances suppressive effects of bone morphogenetic protein 2 (BMP2), BMP4, BMP6 and growth and differentiation factor-9 on FSH release from ovine primary pituitary cell cultures.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7428120f3ad7c1593e45ddd895029c3"><gtr:id>b7428120f3ad7c1593e45ddd895029c3</gtr:id><gtr:otherNames>Young JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>FE21F0009F4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5730309F-6A59-437B-9879-B98C03E49467</gtr:id><gtr:title>Enhanced thecal androgen production is prenatally programmed in an ovine model of polycystic ovary syndrome.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa1786b165b60ceff9c0741dcea3a5cb"><gtr:id>fa1786b165b60ceff9c0741dcea3a5cb</gtr:id><gtr:otherNames>Hogg K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>EJ1ApRseUBP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAEF23C6-22BC-4C98-9669-7BA144B9CC1E</gtr:id><gtr:title>Prenatal androgen exposure leads to alterations in gene and protein expression in the ovine fetal ovary.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa1786b165b60ceff9c0741dcea3a5cb"><gtr:id>fa1786b165b60ceff9c0741dcea3a5cb</gtr:id><gtr:otherNames>Hogg K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>E4auo9eQbcj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96E13B35-B8C0-4F38-A1A8-F52690CDDBCC</gtr:id><gtr:title>Pulsatile patterns of pituitary hormone gene expression change during development.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e785ebe1caadb418083bec7839085582"><gtr:id>e785ebe1caadb418083bec7839085582</gtr:id><gtr:otherNames>Featherstone K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>RuS5YizrWeA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF4DDC1E-93DF-4E52-97B7-DF5B09F0917D</gtr:id><gtr:title>Gonadotrope and thyrotrope development in the human and mouse anterior pituitary gland.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f938a647aadbc57e8a6c1c0299d4833"><gtr:id>9f938a647aadbc57e8a6c1c0299d4833</gtr:id><gtr:otherNames>Pope C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>2E9DBD0DBCC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80CEABBB-C359-415E-BDEB-611C5F82125D</gtr:id><gtr:title>Imaging of the ovine corpus luteum microcirculation with contrast ultrasound.</gtr:title><gtr:parentPublicationTitle>Ultrasound in medicine &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb6b4a211dc9ae6834b823655ccfbdde"><gtr:id>fb6b4a211dc9ae6834b823655ccfbdde</gtr:id><gtr:otherNames>Sboros V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0301-5629</gtr:issn><gtr:outcomeId>UZ9LmxrL4AJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A77810A-D3F0-4C19-AA1A-E8DE6B6D1820</gtr:id><gtr:title>In utero exposure to low doses of environmental pollutants disrupts fetal ovarian development in sheep.</gtr:title><gtr:parentPublicationTitle>Molecular human reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0df40a07210bfd209d7add186c9e432"><gtr:id>d0df40a07210bfd209d7add186c9e432</gtr:id><gtr:otherNames>Fowler PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1360-9947</gtr:issn><gtr:outcomeId>1EF290DE286</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0BB5021-BD01-4E6C-8738-A5A6C4FDE727</gtr:id><gtr:title>Features of follicle-stimulating hormone-stimulated follicles in a sheep model: keys to elucidate embryo failure in assisted reproductive technique cycles.</gtr:title><gtr:parentPublicationTitle>Fertility and sterility</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f38c56ac5eb851fcc875526fd69417af"><gtr:id>f38c56ac5eb851fcc875526fd69417af</gtr:id><gtr:otherNames>Veiga-Lopez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0015-0282</gtr:issn><gtr:outcomeId>F9527F6BEE5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42ADB246-8CC1-4CE4-B66F-B630EC41AF8C</gtr:id><gtr:title>Smooth muscle cell-specific knockout of androgen receptor: a new model for prostatic disease.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2034c2bebf4f8694cade299efecbb4e6"><gtr:id>2034c2bebf4f8694cade299efecbb4e6</gtr:id><gtr:otherNames>Welsh M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>r9DrNPkYi7X</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>960E733D-FD54-4D48-A465-4520FBA732E0</gtr:id><gtr:title>The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa1786b165b60ceff9c0741dcea3a5cb"><gtr:id>fa1786b165b60ceff9c0741dcea3a5cb</gtr:id><gtr:otherNames>Hogg K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>td4S882KLZa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEA31C4D-E59A-44A1-8347-7B208D51B607</gtr:id><gtr:title>The orphan nuclear receptor small heterodimer partner mediates male infertility induced by diethylstilbestrol in mice.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c59beafcf865dd79c83b19f8fe5ebe99"><gtr:id>c59beafcf865dd79c83b19f8fe5ebe99</gtr:id><gtr:otherNames>Volle DH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>5176942F9F4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE991C20-014B-4B2C-AC53-57F951F8094A</gtr:id><gtr:title>Acoustic speed and attenuation coefficient in sheep aorta measured at 5-9 MHz.</gtr:title><gtr:parentPublicationTitle>Ultrasound in medicine &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/469b4db50188125535db53c5bba3ec51"><gtr:id>469b4db50188125535db53c5bba3ec51</gtr:id><gtr:otherNames>Fraser KH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0301-5629</gtr:issn><gtr:outcomeId>CE917D0907F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>015380A9-E4B1-4B04-A9D2-D23BD5E6B8F1</gtr:id><gtr:title>Ovarian endocrine profile and long-term vascular patency following heterotopic autotransplantation of cryopreserved whole ovine ovaries.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a19f0fd43494fdcbc7face8510b1396f"><gtr:id>a19f0fd43494fdcbc7face8510b1396f</gtr:id><gtr:otherNames>Onions VJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>3A8D0E38FB3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5DB1182-D3A7-4485-8731-1F57F698253F</gtr:id><gtr:title>Activin A reduces luteinisation of human luteinised granulosa cells and has opposing effects to human chorionic gonadotropin in vitro.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48530309e0b4b812f741d67dbb62a39f"><gtr:id>48530309e0b4b812f741d67dbb62a39f</gtr:id><gtr:otherNames>Myers M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>CDB1EA01EA5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6799E9C5-FCDF-46C7-87A0-2301B82A9024</gtr:id><gtr:title>Metformin decreases GnRH- and activin-induced gonadotropin secretion in rat pituitary cells: potential involvement of adenosine 5' monophosphate-activated protein kinase (PRKA).</gtr:title><gtr:parentPublicationTitle>Biology of reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/411178cafcd97dad92197ea530e3ac0b"><gtr:id>411178cafcd97dad92197ea530e3ac0b</gtr:id><gtr:otherNames>Tosca L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3363</gtr:issn><gtr:outcomeId>FbqyJVQrFdP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88D52B59-9C47-41BF-94A4-4B6785B57275</gtr:id><gtr:title>Inhibin removes the inhibitory effects of activin on steroid enzyme expression and androgen production by normal ovarian thecal cells.</gtr:title><gtr:parentPublicationTitle>Journal of molecular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7428120f3ad7c1593e45ddd895029c3"><gtr:id>b7428120f3ad7c1593e45ddd895029c3</gtr:id><gtr:otherNames>Young JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0952-5041</gtr:issn><gtr:outcomeId>d4oGdyZxeVe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1DEE63A-EE1A-483C-9457-197AFAD4487B</gtr:id><gtr:title>Cyp11b1 null mouse, a model of congenital adrenal hyperplasia.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb6bbc56240e8474bd79c3869a734e6b"><gtr:id>bb6bbc56240e8474bd79c3869a734e6b</gtr:id><gtr:otherNames>Mullins LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>932C613DA40</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0B0FB81-5BE7-4E05-9AE0-96CDCD371A88</gtr:id><gtr:title>Neonatal estrogenic effects upon the male rat pituitary: early gonadotrophin attenuation precedes long-term recovery.</gtr:title><gtr:parentPublicationTitle>Neuromolecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25ecfa86dc00ea0ff949e06ea4cc9eb6"><gtr:id>25ecfa86dc00ea0ff949e06ea4cc9eb6</gtr:id><gtr:otherNames>Martin B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1535-1084</gtr:issn><gtr:outcomeId>C3612CEFB52</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D24B92F-5A4C-4621-8613-76975FB53F22</gtr:id><gtr:title>Specificity protein 1 (Sp1) plays role in regulating LIM homeodomain transcription factor Lhx4 gene expression.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1aa8b1fe9f61c65a49629023b602564"><gtr:id>e1aa8b1fe9f61c65a49629023b602564</gtr:id><gtr:otherNames>Liu S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>1DEC7AF0738</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A5B12AC-D28F-4645-98CE-1DF34852B0CE</gtr:id><gtr:title>Real-time visualization of human prolactin alternate promoter usage in vivo using a double-transgenic rat model.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82b26c4601743fb8e956df71994ccae1"><gtr:id>82b26c4601743fb8e956df71994ccae1</gtr:id><gtr:otherNames>Semprini S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn><gtr:outcomeId>EAD4030398D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7BF5E11-4E90-495E-B392-CFA7C3785D9B</gtr:id><gtr:title>Long-term levetiracetam treatment affects reproductive endocrine function in female Wistar rats.</gtr:title><gtr:parentPublicationTitle>Seizure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87d9d4720dbda1487dc973efde613db3"><gtr:id>87d9d4720dbda1487dc973efde613db3</gtr:id><gtr:otherNames>Svalheim S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1059-1311</gtr:issn><gtr:outcomeId>2037202D8BB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>447F02ED-F4A6-47BC-B962-1796BC206F04</gtr:id><gtr:title>In vitro evidence suggests activin-A may promote tissue remodeling associated with human luteolysis.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48530309e0b4b812f741d67dbb62a39f"><gtr:id>48530309e0b4b812f741d67dbb62a39f</gtr:id><gtr:otherNames>Myers M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>BCBA38D6959</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8261CCB2-E8E0-4FE7-B680-66ADA9E5A93A</gtr:id><gtr:title>Follicular wave status at the beginning of the FSH treatment modifies reproductive features in superovulated sheep.</gtr:title><gtr:parentPublicationTitle>Reproductive biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f38c56ac5eb851fcc875526fd69417af"><gtr:id>f38c56ac5eb851fcc875526fd69417af</gtr:id><gtr:otherNames>Veiga-Lopez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1642-431X</gtr:issn><gtr:outcomeId>30CE7C3C50C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4167AEC2-C452-4BFF-919A-0CCDDE0E8039</gtr:id><gtr:title>Involvement of the SLIT/ROBO pathway in follicle development in the fetal ovary.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c28551404bc2b202da3d3e5fda1bb112"><gtr:id>c28551404bc2b202da3d3e5fda1bb112</gtr:id><gtr:otherNames>Dickinson RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>pn1UN7DeQS7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDC941CF-AF35-46DD-89C6-01D22358EF79</gtr:id><gtr:title>BMP signaling in the human fetal ovary is developmentally regulated and promotes primordial germ cell apoptosis.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07daa10ef9435bbd86b5b235726d9dca"><gtr:id>07daa10ef9435bbd86b5b235726d9dca</gtr:id><gtr:otherNames>Childs AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>qyCZxMbPAMc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B2B2BFA-7FFC-49A2-B43C-7132D8AE4054</gtr:id><gtr:title>Homozygosity for a single base-pair mutation in the oocyte-specific GDF9 gene results in sterility in Thoka sheep.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63ee45c8bf86bf1fff7e1dacba7321fd"><gtr:id>63ee45c8bf86bf1fff7e1dacba7321fd</gtr:id><gtr:otherNames>Nicol L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>BE17576570F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D46FF398-C1B0-4608-8836-C0F76C5161C4</gtr:id><gtr:title>Cortisol levels are positively associated with pup-feeding rates in male meerkats.</gtr:title><gtr:parentPublicationTitle>Proceedings. Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7400fe5ba53f413e568a8e494be069dd"><gtr:id>7400fe5ba53f413e568a8e494be069dd</gtr:id><gtr:otherNames>Carlson AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0962-8452</gtr:issn><gtr:outcomeId>CAA5B9DDF36</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08498169-068B-48EE-9680-0C89FCD71C96</gtr:id><gtr:title>Dynamic organisation of prolactin gene expression in living pituitary tissue.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64695c4cf41912d695b4888235b3aad4"><gtr:id>64695c4cf41912d695b4888235b3aad4</gtr:id><gtr:otherNames>Harper CV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>PBh5K5dx6h6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5411CC08-9870-4431-9DD7-E4F6FDBAC586</gtr:id><gtr:title>Identification of Eya3 and TAC1 as long-day signals in the sheep pituitary.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d64d54b33dc18fc1b7287c7052fa13d"><gtr:id>0d64d54b33dc18fc1b7287c7052fa13d</gtr:id><gtr:otherNames>Dupr? SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>kt1BbNsovJu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5544FC9-8374-47BE-9973-E5D0DE5C2880</gtr:id><gtr:title>cAMP response element-binding (CREB) signalling and ovarian surface epithelial cell survival.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a59f221ab70a3305d53bc1604374d2b9"><gtr:id>a59f221ab70a3305d53bc1604374d2b9</gtr:id><gtr:otherNames>Gubbay O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>A4B066A9CEB</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U127685843</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>